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Abstract  
In pluripotent cells, a delicate activation-repression balance maintains pro-differentiation genes ready 
for rapid activation. The identity of transcription factors (TFs) that specifically repress pro-differentiation 
genes remains obscure. By targeting ~1,700 TFs with CRISPR loss-of-function screen, we found that 
ZBTB11 and ZFP131 are required for embryonic stem cell (ESC) pluripotency. ZBTB11 and ZFP131 
maintain promoter-proximally paused Polymerase II at pro-differentiation genes in ESCs. ZBTB11 or 
ZFP131 loss leads to NELF pausing factor release, an increase in H3K4me3, and transcriptional 
upregulation of genes associated with all three germ layers. Together, our results suggest that ZBTB11 
and ZFP131 maintain pluripotency by preventing premature expression of pro-differentiation genes and 
present a generalizable framework to maintain cellular potency.  
 
Introduction 
Early developmental progenitors and stem cells can maintain their fate while being able to differentiate 
rapidly. Pluripotency is an example of a transient state during early development, that can be 
recapitulated in vitro with ESCs isolated from the inner cell mass of blastocyst-stage embryos (Evans 
and Kaufman, 1981; Ying et al., 2008). ESCs express pluripotency genes while keeping 
developmentally regulated genes repressed but ready for activation (Bernstein et al., 2006; Mikkelsen 
et al., 2007; Efroni et al., 2008). The ability to rapidly activate pro-differentiation genes is critical for 
pluripotent cells to retain potency for lineage commitment yet differentiate rapidly during development. 
Although essential for understanding pluripotency and differentiation, dedicated TFs that guide 
repression mechanisms to specific pro-differentiation genes are still under investigation.  
Controlling chromatin states and RNA Polymerase II (POL II) elongation dynamics are two major 
mechanisms to maintain plasticity for pro-differentiation gene expression. Bivalent genes contain 
nucleosomes modified by protein complexes associated with active (Trithorax group, TrxG) and 
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repressive (Polycomb group, PcG) transcriptional states (Azuara et al., 2006; Bernstein et al., 2006; 
Vastenhouw and Schier, 2012). Similarly, reducing other chromatin modifiers such as histone 
deacetylase 1/2 (HDAC1/2) complexes leads to the upregulation of pro-differentiation genes 
(Kawamura et al., 2005; Karantzali et al., 2008; Dovey, Foster and Cowley, 2010; Jamaladdin et al., 
2014). Regulating POL II elongation dynamics by promoter-proximal pausing has emerged as a 
possible mechanism to repress pro-differentiation genes while preserving the ability to produce full-
length transcripts (Stock et al., 2007; Ferrai et al., 2017). Genes with promoter-proximal paused POL 
II can be rapidly transcribed, an ideal state for cell fate transitions during early development. In 
pluripotent stem cells, POL II pausing restricts the expression of pro-differentiation genes (Stock et al., 
2007; Adelman and Lis, 2012; Marks et al., 2012). However, chromatin modifiers and POL II lack the 
sequence-specificity and must be recruited to a specific set of pro-differentiation genes that must be 
kept ready for activation.  
Sequence-specific TFs are excellent candidates for recruiting and modulating chromatin complexes 
and POL II to regulate pro-differentiation genes. The pluripotency gene regulatory network (PGRN) 
relies on a set of interconnected TFs that engage in a positive feedforward loop to activate pluripotency 
genes (Li and Izpisua Belmonte, 2018). Moreover, the PGRN core TFs, OCT4, NANOG, and SOX2, 
directly bind to pluripotency and differentiation genes which must be actively maintained in a repressed 
state (Boyer et al., 2005). Ad hoc repressive TFs that establish and control poised chromatin states in 
embryonic stem cells were postulated more than a decade ago (Boyer et al., 2005; Creyghton et al., 
2008; Surface, Thornton and Boyer, 2010). However, a full understanding of sequence-specific 
repressive TFs that regulate the wide variety of genes required for the differentiation into all germ layers 
had remained elusive. 
To rapidly dissect the gene regulatory network of ESCs, we developed a loss-of-function screen with a 
pooled CRISPR/Cas9 library targeting all annotated TFs in the mouse genome. The screen recovered 
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known PGRN members (OCT4, NANOG, etc.) as well as two non-redundant ZBTB family TFs: ZBTB11 
and ZFP131. ZBTB11 and ZFP131 co-occupy transcription start sites (TSS) of pro-differentiation genes 
along with TrxG, POL II, and NELF. Mutations of Zbtb11 or Zfp131 caused a decrease in NELF and an 
increase in H3K4me3 signal at their binding sites, which coincides with increased transcription of 
associated genes. As a result, ZBTB11 or ZFP131 loss causes transcriptomic changes associated with 
ESC differentiation into all three germ layers. Thus, we propose that ZBTB11 and ZFP131 play non-
redundant roles as pluripotency gatekeepers to maintain developmental regulators in a repressed state 
but ready to be activated by restricting POL II elongation.  
 
Results 
A CRISPR loss-of-function screen to identify transcription factors required for pluripotency  
To functionally identify TFs with essential roles during differentiation or fate maintenance, we designed 
and constructed a rapid and efficient CRISPR-Cas9 loss-of-function screen targeting all 1,682 
annotated TFs in the mouse genome (“CRISPR TF library”) (Table S1) (Ravasi et al., 2010; Meier, 
Zhang and Sanjana, 2017). The CRISPR TF library contains 10 single guide RNAs (sgRNAs) per TF 
and 1000 non-targeting sgRNAs (~5% of all sgRNAs) to serve as negative controls. We selected 
sgRNAs with predicted high on-target activity (Doench et al., 2016), minimal potential for off-target (Hsu 
et al., 2013), and those that target 5’ exons with annotated functional domains to enrich for loss-of-
function mutations (Shi et al., 2015) (Figure S1A-C, Table S1).  
Because of their rapid cell cycle, bona fide ESCs outcompete differentiating cells or cells with 
compromised self-renewal abilities, a demonstrated advantage in identifying pluripotency and self-
renewal genes (Ivanova et al., 2006). Thus, ESCs transduced with sgRNAs targeting PGRN TFs should 
differentiate and be outcompeted by ESCs transduced with non-targeting sgRNAs and those targeting 
TFs that do not affect ESC state. A pilot competition assay using a non-targeting sgRNA versus 
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sgRNAs targeting Oct4 (Pou5f1), Nanog, and Klf5 (Figure S2A) revealed that cells transduced with 
sgRNAs targeting PGRN TFs were outcompeted starting by 5 days after transduction and were almost 
fully depleted by day 12 (Figure S2B). Therefore, we measured CRISPR TF library sgRNA 
representation on day 5, day 8, and day 12 after ESC transduction (Figure 1A). As expected, the sgRNA 
library diversity progressively decreased, as mutant cells for essential and pluripotency TFs were 
outcompeted over time (Figure 1B) (Shannon, 1948). To select candidate TFs, we used three different 
methods to identify significantly depleted sgRNAs: an empirical false discovery rate (FDR) cutoff 
derived from the embedded 1000 non-targeting sgRNAs controls (Chen et al., 2015; Patel et al., 2017), 
a mixed linear model with random intercepts using normalized sgRNA counts, and Model-based 
Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method (Li et al., 2014).  
In the first approach, by measuring the depletion of the non-targeting sgRNAs, we set an empirical FDR 
cutoff of q < 0.05 and calculated the number of depleted sgRNAs per gene that exceeded this level 
(Figure 1C, S2C, D). Random permutation simulations demonstrated that at least 6 depleting or 3 
enriching sgRNAs are required to confidently categorize a gene as a depleting or enriching, respectively 
(Figure 1D, S2E). In total, the empirical FDR method identified 262 depleting candidate TFs (Figure 
1E). Although not the focus of this study, using an enrichment analysis, the empirical FDR method also 
identified 17 genes that increased self-renewal when mutated. These include the tumor suppressor 
Trp53 (p53) and other genes which could provide growth advantage in cancers when mutated (Figure 
S3) (Cerami et al., 2012; Gao et al., 2013; Merkle et al., 2017). In the second approach, the mixed 
linear model identified 218 depleting TFs (Figure 1E, S4A), and by using the degree of depletion placed 
candidate TFs within the PGRN hierarchy (Figure S4A, Table S2) (see methods). Finally, the MAGeCK 
approach identified 302 TF candidates as significantly depleted using robust-rank aggregation (Figure 
1E, Table S2). In total, the three methods identified 196 TFs in common. As expected, this set included 
positive controls like essential genes and many known pluripotency factors. After removing these 
factors from this set, we selected 7 high-confidence novel candidate TFs (Ankrd49, Zbtb10, Zbtb11, 
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted November 23, 2020. ; https://doi.org/10.1101/2020.11.23.391771doi: bioRxiv preprint 
Page 6 of 39 
 
Zeb1, Zfp131, Zfp638, Znhit3) with high scores and unknown functions to be tested for their putative 
role in pluripotency (Table S2).    
 
A secondary screen identifies ZBTB domain containing TFs as novel candidates for PGRN   
Disrupting pluripotency or self-renewal decreases the ESCs’ proliferation rate. To discriminate between 
effects on pluripotency and self-renewal, we utilized a dual-color pluripotency reporter ESC line (Figure 
1F). We generated an Oct4:: tdTomato and Sox2::Gfp pluripotency reporter line. When transduced with 
non-targeting sgRNAs, 85% of ESCs expressed both GFP and TDTOMATO (Figure 1G). In contrast, 
only 45 - 65% of cells transduced with sgRNAs targeting Klf5, Nanog, or Oct4 expressed both 
fluorescent proteins under these culture and infection conditions (Figure 1G). We transduced the 
pluripotency dual-color reporter ESC line with two sgRNAs targeting each candidate TF (Figure 1F). 
To ensure robust, independent validation, we made sure that at least one sgRNA for each gene was 
not found in our original set of 10 sgRNAs per TF (Table S3). Transduction with sgRNAs targeting 
Zbtb10, Zbtb11, and Zfp131 reduced OCT4 and SOX2 reporters similarly to the known pluripotency 
TFs (Figure 1G). In contrast, sgRNAs targeting Zfp638, Ankrd49, Znhit3, and Zeb1 did not significantly 
reduce OCT4 and SOX2 reporter expression. We did not continue our investigation on these TFs since 
they are likely to control self-renewal or other ESC features, but not pluripotency. 
A sgRNA competition assay between Zbtb10, Zbtb11, and Zfp131 targeting sgRNAs and non-targeting 
sgRNA (Figure S5A) demonstrated that Zbtb11 and Zfp131 sgRNAs depleted as fast as the core PRGN 
Oct4 and Nanog sgRNAs (Figure S5B, S2A, B). Zbtb10 depleted slower as Klf5 (Figure S5B, S2A, B). 
The comparative depletion rate in the competition assay is in line with the original screen (Figure S4). 
Moreover, we performed a similar CRISPR TF screen using a library targeting all human TFs with 10 
sgRNAs per gene and found that sgRNAs targeting the human homologs of Zbtb10, Zbtb11, and 
Zfp131 are also depleted in human pluripotent stem cells (Figure S6). Thus, a rapid TF-wide screen 
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combined in mouse and human ESC with a small-scale secondary screen using dual fluorescent 
reporter line was sufficient to identify novel candidate TFs for PGRN.  
 
Zbtb11 and Zfp131 are required for pluripotency  
Zbtb10, Zbtb11, and Zfp131 are C2H2 Zinc Finger BTB Domain TFs expressed in ESCs and during 
early mouse and human development (Boroviak et al., 2018; Nowotschin et al., 2019). To better 
characterize their role in pluripotency, we generated clonal ESC lines carrying null alleles for each TF. 
We introduced small frameshift deletions in the endogenous alleles while supplying an exogenous 
doxycycline-inducible HA-tagged rescue copy (Figure S5C). The addition of the HA-tag does not disturb 
ESC morphology or Oct4 expression (Figure S5D, E). Doxycycline removal causes the extinction of the 
rescue construct, and consequently, ESCs only express null alleles for each candidate TFs (Zbtb10Δ, 
Zbtb11Δ, or Zfp131Δ thereafter). To validate the competitive disadvantage seen during the screen, we 
repeated the competition assay with H2B-GFP labeled wildtype (wt) ESCs plated in equal proportions 
with Zbtb10Δ, Zbtb11Δ, or Zfp131Δ ESCs (Figure S7A). Although there was a slight decrease, the 
H2B-GFP labeled wt ESCs did not significantly outcompete the Zbtb10Δ ESCs (Figure S7B). In 
contrast, the H2B-GFP labeled wt ESCs significantly outcompeted Zbtb11Δ and Zfp131Δ cells (Figure 
S7B). 
Mouse ESCs grow in compact colonies and are typically cultured with LIF and with or without 2i 
compounds (MEK and GSK3 inhibitors) (Ying et al., 2008). Zbtb11Δ and Zfp131Δ cells lost ESC 
morphology both with and without 2i (Figure 2A), and the number of OCT4 expressing cells decreased 
in Zbtb11Δ and Zfp131Δ (Figure S7C). On the other hand, Zbtb10Δ cells looked similar to wt cells 
(Figure 2A) and the number of OCT4-positive cells was mildly reduced in the Zbtb10Δ line (Figure 
S7C).   Together, the characterization of clonal mutant lines confirms that ESCs require ZBTB11 and 
ZFP131, however, loss of ZBTB10 is not drastically affecting pluripotency features.   
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Loss of Zbtb11 and Zfp131 compromises pluripotent stem cell fate  
Morphological changes of mutants described above led us to hypothesize that Zbtb11Δ and Zfp131Δ 
ESC would induce genes associated with cell differentiation. To test this hypothesis, we performed bulk 
RNA-seq on mutant cells from cells grown in LIF with and without and 2i. The transcriptome of Zbtb10Δ 
was similar to wt ESCs (Figure 2B, S8A). On the other hand, Zbtb11 and Zfp131 mutations induced 
severe transcriptome alterations in ESCs (Figure 2B, S8A). For example, Zbtb11Δ cells downregulated 
301 and upregulated 795 genes, and Zfp131Δ cells downregulated 392 and 1189 upregulated genes 
without the 2i compounds.  
Hierarchical clustering grouped each mutant according to their transcriptome (Figure 2C). Zbtb10Δ cells 
group together regardless of the culture conditions. On the other hand, Zbtb11Δ and Zfp131Δ 
separated from control ESCs independently of culture conditions (Figure 2C). Principal Component 
Analysis (PCA) of RNA-seq samples revealed a similar finding (Figure 2D). The two PCA dimensions 
explain 68.33% variance with the samples separated by genotype in the PC1 dimension (48.15% of 
the variance), while PC2 (20.18% of the variance) is the effect of removing 2i from the media. 
Interestingly, Zbtb11 and Zfp131 mutant cells are still sensitive to 2i removal, suggesting that they 
respond to Wnt and MEK signaling. Because of the slight growth disadvantage and the relatively small 
transcriptomic differences, we speculate that Zbtb10 is not a central factor required for pluripotency. 
We conclude that Zbtb11 and Zfp131 are required for pluripotency because of the strong morphological 
and transcriptional changes in Zbtb11Δ and Zfp131Δ cells even in strong pluripotency maintaining 
conditions.  
To understand ZBTB11 and ZFP131 in maintaining pluripotency, we characterized the set of 
dysregulated genes in their respective mutant lines. Notably, both mutant lines induced a strong 
differentiation signature in culture conditions with and without 2i compounds. Upregulated genes in 
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Zbtb11Δ and Zfp131Δ cells are associated with cell differentiation GO-terms. Importantly, those include 
cell fate commitment, morphogenesis, and tissue development (Figure 2E, F, S8B-C). We also 
detected downregulated mitochondrial and other cellular biosynthetic and metabolic processes genes 
in Zbtb11Δ and Zfp131Δ ESCs (Figure S8D-F) (Wilson et al., 2019). Thus, Zbtb11 and Zfp131 
mutations caused profound transcriptional changes indicative of cell differentiation in the two most 
common ESC culture conditions.  
 
Zbtb11 and Zfp131 mutations induced ESCs to express genes associated with all three germ layers 
We next asked if ZBTB11 and ZFP131 repress a unique differentiation trajectory each or if they repress 
the expression of genes associated with all three germ layers.  Both mutants significantly 
downregulated pluripotency TFs and upregulated TFs associated with mesoderm, endoderm, 
ectoderm, and trophectoderm development compared to wt ESCs (Figure 3A). We did not detect any 
strong upregulation of genes associated with germline and primordial germ cells (Figure S8G). These 
results indicated that ZBTB11 and ZFP131 TFs are required for pluripotency maintenance with 
repressing pro-differentiation genes.  
The observed upregulation of developmental genes in bulk RNA-seq offered two alternative scenarios: 
mutant cells differentiate into multiple germ layer trajectories, or each cell simultaneously expresses 
genes of various germ layers. To discriminate between these two alternatives, we performed single-
cell RNA sequencing (scRNA-seq). We mixed Zbtb11Δ or Zfp131Δ cells with H2B-GFP expressing wt 
ESCs to landmark control ESC expression in each experiment. H2B-GFP expressing wt naïve stem 
cells cluster away in both analyses with a high expression of stem cell markers (Cluster 6 in Zbtb11Δ 
Figure 3B and Cluster 4 in Zfp131Δ Figure 3E). Zbtb11Δ and Zfp131Δ each formed distinct clusters.  
Zbtb11Δ cells were grouped in clusters with different germ layers markers (Figure 3C, D). For example, 
cluster 3 contained cells expressing ectoderm markers, while cluster 4 was associated with markers of 
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mesoderm fate (Figure 3C, D). Cluster 5 included cells expressing genes related to endoderm (Gata4, 
Gata6, Sox7). Zfp131Δ clusters express genes associated with different germ layers with endoderm in 
cluster 6 and mesoderm markers in Cluster 7 (Figure 3F, G). Zfp131Δ cells upregulated ectodermal 
markers (Otx2, Neurod1, Id2) across several clusters (Figure 3G). Although Zbtb11Δ and Zfp131Δ 
clusters separated from ESCs, a portion of cells retained the expression of the pluripotency factors 
Sox2 and Nanog (Figure 3D, G). This co-expression can be due to either capturing an early 
differentiation phase or aberrant expression. Together, neither Zbtb11Δ nor Zfp131Δ cells were 
grouped with wt ESCs nor formed a single cluster with each cell co-expressing genes from all germ 
layers. From the bulk and scRNA-seq analysis, we conclude that ZBTB11 and ZFP131 maintain the 
pluripotent state by actively repressing multiple developmental regulatory programs with each forming 
its own cluster and not one specific differentiation trajectory even with some aberrant gene 
combinations.  
 
ZBTB11 and ZFP131 bind to sites without classic repressive chromatin features  
To gain insights into how ZBTB11 and ZFP131 maintain pluripotency and repress differentiation 
programs, we investigated the genomic binding of them in undifferentiated pluripotent cells. MultiGPS 
ChIP-seq analysis of HA-tagged exogenous copies identified 22,439 ZBTB11 sites and 3,635 ZFP131 
binding sites (Mahony et al., 2014). The majority of ZFP131 binding sites (78%) overlap with ZBTB11 
(Figure 4A). BTB domains participate in homo and heterodimer formation, suggesting these two TFs 
could coregulate this set of genes (Stogios et al., 2005). Both ZBTB11 and ZFP131 co-bound sites 
(Z11=Z131) and ZBTB11 only sites (Z11>Z131) contain a central motif similar to that bound by ETS 
family TFs: CCGGAA (Figure 4B). ZFP131 and ZBTB11 co-bound sites (Z11=Z131) and ZFP131 only 
sites (Z131>Z11) contain a central motif similar to that bound by bZIP TFs: TGACGTCA (Figure 4B). 
Using the GREAT algorithm (McLean et al., 2010), we found that the majority of ZBTB11 and ZFP131 
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sites are proximal to TSSs. 46% of ZBTB11 binding and 72% of ZFP131 binding lies within 5 kb of 
nearest TSSs (Figure S8H, I). Comparing ZBTB11 and ZFP131 binding with ESC ATAC-seq 
experiments revealed that ZBTB11 and ZFP131 associate with accessible chromatin regions (Figure 
4C) (Velasco et al., 2017). These sites are also enriched in histone modifications associated with active 
transcription elements (H3K27ac) and promoter regions (H3K4me3) (Figure 4C). We noted these sites 
are also largely devoid of repressive histone modifications such as H3K9me3 and H3K27me3 (Figure 
4C) (Bilodeau et al., 2009). Therefore, ZBTB11 and ZFP131 bind at gene proximal sites containing an 
overall active chromatin signature. 
We considered several hypotheses that could explain how Zbtb11 and Zfp131 maintain pluripotency. 
The ZBTB family TF ZBTB3 occupies the ESC genome with core pluripotency factors to modulate their 
activity (Ye et al., 2018). However, low ZBTB11 and ZFP131 binding overlap (<5%) with OCT4, SOX2, 
and NANOG do not support the hypothesis of co-regulation between ZBTB11 or ZFP131 and 
pluripotency factors (Figure 4C). ZBTB TFs are also known to interact with the subunits of histone 
deacetylase complexes (David et al., 1998; Maeda, 2016; Masuda et al., 2016). Both ZBTB11 and 
ZFP131 overlap with sites occupied by CHD4 and SIN3A, known components of different histone 
deacetylase complexes (Figure 4C, Figure S9A-B) (Laherty et al., 1997; Xue et al., 1998). While there 
were small CHD4 and SIN3A decreases at ZBTB11 and ZFP131 sites in Zbtb11Δ or Zfp131Δ cells 
(Figure S9C-F), these areas lost H3K27ac, which is contrary to expectation when losing HDACs (Figure 
S9G, H). Overall, H3K27ac deposition did not correlate with significantly decreased or increased CHD4 
and SIN3A in Zbtb11Δ or Zfp131Δ. Thus, these results do not support a direct role in HDAC recruitment. 
 
ZBTB11 and ZFP131 prevent TrxG activation  
ZBTB11 and ZFP131 TSS-proximal binding suggest that they could maintain a poised state at pro-
differentiation genes. However, ZBTB11 or ZFP131 sites do not overlap with high levels of H3K27me3, 
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indicating that their target genes do not rely on PRC2 repression (Figure 4C). Therefore, our data do 
not support ZBTB11 and ZFP131 binding as a mechanism to recruit PcG to maintain the bivalent state 
of developmentally regulated genes in ESCs.  
ZBTB11 and ZFP131 binding overlaps with H3K4me3, which is deposited by TrxG (Figure 4C). Among 
the TrxG H3K4me-depositing enzymes, SETD1A is expressed and required at early developmental 
states until inner cell mass formation in development (Bledau et al., 2014). SETD1A binding overlaps 
significantly with ZBTB11 and ZFP131 in wt ESCs (Figure 4C, 5A, 5B) (Sze et al., 2017). Removing 
ZBTB11 or ZFP131 induced a significant increase of H3K4me3 at their binding sites (Figure 4D, E). 
This increase was even more prominent at sites where ZBTB11 and ZFP131 binding overlaps 
(ZBTB11=ZFP131) (Figure 4F). Importantly, most of the regions that gained H3K4me3 in Zbtb11Δ and 
Zfp131Δ cells already contained SETD1A binding in the wt state (Figure 5C-E). Genes that were bound 
by ZBTB11 or ZFP131 that gained H3K4me3 and mRNA upregulation in mutant lines are strongly 
associated with differentiation GO terms (Figure 5F, G). These genes included Gata6, Sox7, Id3, Snai1, 
Sox17, Onecut1, Nkx2.2, and Gata3 pro-differentiation TFs. Therefore, our results suggest that 
ZBTB11 and ZFP131 bind to a subset of pro-differentiation genes that already contain SETD1A the 
TrxG complex in ESCs. Upon ZBTB11 or ZFP131 removal, these sites gained H3K4me3 with the 
associated gene transcription, particularly at ZBTB11 and ZFP131 co-bound sites. We conclude that 
ZBTB11 and ZFP131 are the sequence-specific TFs that maintain sufficient repression force to prevent 
premature pro-differentiation gene upregulation and spontaneous pluripotent stem cell differentiation.  
 
ZBTB11 and ZFP131 regulate promoter-proximal POL II pausing at pro-differentiation genes 
Low H3K27me3 signal at ZBTB11 and ZFP131 bound sites indicate that these TFs are not regulating 
bivalent chromatin, therefore we sought to investigate if ZBTB11 and ZFP131 regulate POL II 
elongation dynamics. POL II carboxyl-terminal domain (CTD) contains repeats of the Y1S2P3T4S5P6S7 
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amino acid sequence, which is unphosphorylated during POL II recruitment to the TSSs (Hsin and 
Manley, 2012). POL II is loaded onto TSSs, forming a complex with the negative elongation factor 
(NELF) among other factors, pausing proximal to the TSS (Yamaguchi et al., 1999; Muse et al., 2007; 
Zeitlinger et al., 2007). Following initial elongation, POL II is phosphorylated at serine 5 (S5P), but 
further elongation is enabled by serine 2 phosphorylation (S2P) and with NELF removal (Egloff, 
Dienstbier and Murphy, 2012).  
Both ZBTB11 and ZFP131 overlap with serine 5 phosphorylated POL II (POL II S5P) (Figure 4C, 6A). 
Moreover, these sites also contain NELF (Figure 4C, 6A). ZBTB11 and ZPF131 removal decreased 
NELF binding at these sites (Figure 6B). Genes containing POL II S5P, NELF, and either ZBTB11 or 
ZFP131 were upregulated in Zbtb11Δ and Zfp131Δ cells (Figure 6C-D). In agreement with chromatin 
phenotypes, the transcription of genes associated with co-bound sites (ZBTB11=ZFP131) was strongly 
upregulated (Figure 6E-F). These results suggest that ZBTB11 or ZFP131 removal causes NELF 
displacement, allowing POL II to engage in transcription elongation, leading to transcriptional 
upregulation.   
Together, our results show that ZBTB11 and ZFP131 bind proximally to developmentally regulated 
genes to regulate POL II elongation dynamics. These genes contain SETD1A, low H3K4me3 levels, 
and promoter-proximal paused POL II along with NELF (Figure 7) but have restricted expression in 
ESCs. Upon ZBTB11 and ZFP131 removal, their target genes gain H3K4me3, decommission NELF, 
and upregulate transcription (Figure 7). ZBTB11 and ZFP131 are not redundant since individual 
mutants have phenotypes and associated genes at co-bound sites are also subjected to this regulation. 
Thus, ZBTB11 and ZFP131 provide repression with POL II pausing to maintain pro-differentiation 
genes at a delicate activation-repression balance to preserve pluripotency.   
 
Conclusions 
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Transcription factors are critical regulators of cell fate, typically playing instructive roles in cell fate 
maintenance and differentiation. Decades of screens and studies have yielded a profound 
understanding of the functions of many TFs. However, there is still an overwhelmingly large fraction of 
TFs with no described role, even in one of the most molecularly well-characterized cellular states: 
pluripotent stem cells. To gain insights into TF-driven gene regulatory networks, we designed a loss-
of-function CRISPR-Cas9 screen targeting all annotated TFs in the genome and deployed this unique 
tool to identify key TFs that regulate pluripotency. We expect this strategy to shed light on other TF-
dependent regulatory processes such as differentiation and development of diverse cell lineages.  
The PGRN is composed of interlocked activating TFs. At its core, the OCT4-SOX2 complex binds with 
other partners, including NANOG, in a strong pluripotency positive feedback loop (Boyer et al., 2005; 
Kim et al., 2008; Festuccia et al., 2012). OCT4 and SOX2 bind proximally to pro-differentiation genes 
(Boyer et al., 2005; Jaenisch and Young, 2008); however, these TFs are not ad hoc repressors 
suggesting additional TFs with repressive functions are required. With the TF-focused loss-of-function 
screen, we uncovered a novel role for the BTB-domain ZBTB11 and ZFP131 TFs. Pluripotency requires 
Zbtb11 and Zfp131, and their mutations upregulate the expression of genes associated with 
differentiation to all three germ layers. ZBTB11 and ZFP131 do not cooccupy ESC chromatin with core 
pluripotency TFs, thus unlikely to form a repressive complex with OCT4-SOX2. ZBTB TFs generally 
have repressive roles with BTB domains interacting with HDACs, nuclear co-repressors (NCoR1), 
silencing mediator of retinoic acid and thyroid hormone receptor (NCoR2/SMRT), and Sin3A (Bardwell 
and Treisman, 1994; Albagli et al., 1995; Melnick et al., 2002; Ahmad et al., 2003; Ghetu et al., 2008). 
However, ZBTB11 and ZFP131 binding neither overlap with NCOR nor impact histone deacetylase 
activity. Finally, ZBTB11 and ZFP131 binding does not overlap with bivalent genes or PcG deposited 
H3K27me3 signal, suggesting they have no role in bivalent chromatin state regulation.  
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Rapid gene activation during cell differentiation can be controlled by regulating POL II pausing and 
elongation (Guenther et al., 2007; Marks et al., 2012). Characterizing POL II pausing in wt and POL II 
pausing-deficient cells suggested that around 40% of all developmental regulators contain paused POL 
II at their TSSs (Williams et al., 2015). We propose that ZBTB11 and ZFP131 prevent aberrant induction 
of pro-differentiation genes in pluripotent stem cells by establishing or maintaining POL II pausing 
(Figure 7). Genetic ablation of NELF does not cause a differentiation phenotype, whereas resulting in 
profound effects in cell growth, metabolism, and kinase activity (Williams et al., 2015). We speculate 
that these phenotypic differences are due to ZBTB11 or ZPF131 affecting a subset of NELF bound 
genes, contrary to the pleiotropic effect seen in the NELF mutant. Another ZBTB TF family member, 
ZBTB17 (MIZ-1) was previously described to repress a set of Hox genes in pluripotent stem cells 
(Varlakhanova et al., 2011). It would be interesting to test if ZBTB17 uses a similar repression 
mechanism as ZBTB11 and ZFP131.  
The BTB domain can form homo and heterodimers (Stogios et al., 2005). The similar phenotype of both 
mutants and the binding overlap, particularly for ZFP131, suggest that they might coregulate a set of 
developmentally regulated genes. Moreover, a larger overlap is conceivable if a higher number of sites 
could be recovered from ZFP131 ChIP. The fact that both genes were recovered from the functional 
screen with a similar phenotype for each mutant suggests that these TFs perform similar but non- 
redundant functions to maintain pluripotency.   
Zbtb11 and Zfp131 are expressed in pluripotent stem cells and at early pluripotent developmental 
stages (Boroviak et al., 2018; Nowotschin et al., 2019). Although pluripotency can be maintained 
indefinitely by chemical signals in vitro, it is a transient in vivo state. We speculate that ZBTB11 and 
ZFP131 safeguard the transient state of pluripotency by preventing premature activation of 
differentiation during development. Broadly, the temporal gene activation in pluripotent and multipotent 
states is tightly regulated during vertebrate development. Since only a fraction of all TFs expressed 
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during development are functionally characterized, we predict that TFs similar to ZBTB11 and ZFP131 
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Methods 
Generation of stem cell lines and culture conditions 
A17 E14Tg2a line was used for the initial CRISPR TF screen experiments (Iacovino et al., 2011). 
Zbtb11 and Zfp131 were amplified from cDNA of ESCs using Zbtb11-fwd (5’ 
ATGTCAAGCGAGGAGAGCTACC), Zbtb11-rvs (5’ CTCTGCCTCTGGCATATGTGC), Zfp131-fwd 
(5’ ATGGAGGCTGAAGAGACGATGG) and Zfp131-rvs (5’ TTCTAAAACCGGCAGAGATGTCC) 
primers. The cDNA of Zbtb10 was amplified from Origene (MR214195L4) Zbtb10 mouse tagged 
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ORF clone using Zbtb10-fwd (5’ ATGTCGTTCAGTGAGATGAACCG) and Zbtb10-rvs primer (5’ 
TCCAGAGACATAAACGCCTCC). C-terminus of Zbtb10, Zbtb11, and Zfp131 cDNAs were fused to 1x 
hemagglutinin (HA) tag and cloned into p2lox plasmid using In-fusion (Clontech) cloning. To avoid 
sgRNAs from both landing on exogenous alleles and Cas9 from cutting at the PAM site, the sgRNA 
docking site on the BTB domain sequence of Zbtb10, Zbtb11 and Zfp131 was altered without changing 
the amino acid sequence (Figure S6A). Resulting CRISPR-proof alleles in p2lox-Zbtb10-HA, p2lox-
Zbtb11-HA, p2lox-Zfp131-HA were nucleofected into mouse ESCs grown in 1 µg ml–1 doxycycline 
(Sigma, D9891) to induce iCre expression for 16h. Successfully inserted transgenes were selected 
using G418 selection (400 µg ml–1, Cellgro) and characterized for expression of tagged transgenic 
proteins with HA staining (anti-HA, ab9110). 
To knock out endogenous alleles of Zbtb10, Zbtb11, and Zfp131, inducible Zbtb10-HA, Zbtb11-HA and 
Zfp131-HA lines were nucleofected with CMV-GFP and pTF vector (Figure S1D). Two pTF vectors with 
sgRNAs targeting 100 bp apart from each other with Zbtb10 sgRNAs (5’ TCTTTGTGATGTCAGCATTG 
and 5’ AGAAACGGCTGCCTGCAACC), Zbtb11 sgRNAs (5’ AGCGCACAAGTCTGTCCTCT and 5’ 
AGGAGCAGTTTCTAGTCACG), and Zfp131 sgRNAs (5’ TGTATGTGAACTCAATTAAG and 5’ 
AAGAAGAAGCCAATGATGTG). GFP expressing clones were sorted with a fluorescent activated cell 
sorter (FACS, BD FACSAria II) 48 h after nucleofection and cells were plated at a single-cell density. 
Clones were picked after 9 days and knockout alleles were verified by genotyping PCR. 
H2B-GFP line was generated by nucleofecting the H2B-GFP plasmid (Addgene #11680) into the A17 
E14Tg2a line. Randomly inserted H2B-GFP expressing cells were selected clonally and verified by live 
nuclear GFP expression under Nikon Perfect Focus Eclipse Ti live-cell fluorescence microscope and 
with FACS Aria. 
The Oct4::tdTomato Sox2::Gfp line was generated by inserting an IRES-dtTomato cassette (Swanzey 
and Stadtfeld, 2016) into the 3’UTR of the endogenous Oct4 locus to KH2-OKSM ESCs (Stadtfeld et 
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al., 2010) similarly as previously described (Lengner et al., 2007). This was followed by heterozygous 
insertion of an EGFP cassette in the position of the start codon of the endogenous Sox2 locus, using a 
previously described targeting vector (Ellis et al., 2004). 
Cell Culture 
ESCs were cultured on 0.1% gelatin (Milipore) coated dishes at 37 °C, 8% CO2 in ESC medium 
(Advanced DMEM/F12: Neurobasal (1:1) Medium (Gibco), supplemented with 2.5% mESC-grade 
fetal bovine serum (Corning), 1x N2 (Gibco), 1x B27 (Gibco), 2 mM L-glutamine (Gibco), 0.1 mM ß-
mercaptoethanol (Gibco)) supplemented with LIF (leukemia inhibitory factor, 1,000 U ml–
1  (Millipore)) and 2-inhibitor cocktail (3 mM CHIR (BioVision) and 1 mM PD0325901 (Sigma)) unless 
stated otherwise.   
Library Cloning 
Synthesized oligonucleotides (Twist Bioscience) were dissolved in Buffer EB (Qiagen). 16 ng/uL single-
stranded pooled oligos were amplified with NEBNext High-Fidelity 2X PCR Master Mix (NEB) with the 
following PCR protocol: Denaturation 98 °C for 30s, 8 cycles of 98 °C for 10s, 63 °C for 10s, 72 °C for 
15s, final elongation 72 °C for 3 min. 40 µg pTF vector containing sgRNA-E+F scaffold with U6 
promoter and Cas9-P2A-Zeocin with EFS-NS promoter is digested with Esp3l (Thermo Scientific) in 
FastDigest Buffer (10X, Thermo Scientific) and 1mM DTT in 100 uL (Chen et al., 2013). The digested 
vector is also dephosphorylated in FastAP Thermosensitive Alkaline Phosphatase (1U/µL, Thermo 
Scientific) in FastDigest Buffer (10X) in 200 µL volume. Purified pooled oligos were cloned into 
digested pTF vector using 2X Gibson Assembly Master Mix with 10 times molar ratio of pooled oligos 
to digested vector and transformed to competent E.coli and plated on LB+Amp plates (Figure S1D). 
565 E.coli colonies per guide ratio (>500x coverage) was used to process the 4 Maxi-Prep (Qiagen) 
reactions. After bacterial transformation, the plasmid library was sequenced to verify uniform sgRNA 
coverage and minimal bias (Figure S1E). 
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Lentiviral packaging 
12.5 million 293T (ATCC CRL-3216) cells were plated on 4 T225 flasks and grown in DMEM with high 
glucose, pyruvate (Thermo Scientific) with 10% FBS (Corning), and 2 mM L-glutamine (Gibco). When 
the cells were 90% confluent, 12.5 mL Opti-MEM with 630 µL Lipofectamine 3000 (Thermo Scientific) 
was mixed with 12.5 mL of Opti-MEM containing 61.2 µg of pMD2.G, 93.6 µg of psPAX2 and 122.4 µg 
of CRISPR TF library and 540 µl of P3000 enhancer (Thermo Scientific). After the mixed solution was 
incubated for 15 min, 6.5 mL of transfection mix is transferred per T225. 5 hours later, media containing 
the transfection mix was replaced with fresh DMEM with 10% FBS. 48h later, the supernatant 
containing lentivirus was collected from 4 T225 flasks and spun down at 1000 x g for 5 min at 4 °C to 
remove debris. The pooled virus-containing supernatant was filtered through a 0.45 µM PES membrane 
(VWR). The filtered supernatant was then spun in an ultracentrifuge for 2 hours at 20,000 g at 4 °C. 30 
mL of the supernatant obtained per T225 was concentrated in 300 µL PBS1X containing 10% BSA 
(Sigma). Aliquots were frozen at -80 °C. To prepare individual sgRNA viruses, the above-mentioned 
protocol for T225 was scaled down to p100 and PEI was used to replace Lipofectamine 3000. 1:2.54 
DNA to PEI ratio was used for p100. 
Mouse TF CRISPR Screen 
3 x 106 ESC cells were distributed to 5 12-well dishes (Thermo Scientific) with 5 x 105 mESC cells per 
well. 4 h after cells were plated, the media was replaced with 8 µL of 100x concentrated library lentivirus 
mixed in 1 mL ESC medium with 1x polybrene (EMD Millipore). 16 h later, the virus solution was 
removed, cells were washed 1 time with PBS1X, and cells were split 1:2 to 10 12-well plates. 50 ng/µL 
Zeocin (Invivogen) was added to each well 24h later and transduced cells were maintained with Zeocin 
selection. To maintain 50-70% confluency throughout the screen, cells were transferred to 6-well plates 
(Thermo Fisher) on day 2 and selected for 3 additional days for a total of 5 days of selection. The first 
time point was obtained on day 5 post-selection. The second and third timepoints were taken on day 8 
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and day 12 while growing in ESC medium containing 50 ng/µL Zeocin.  
We performed library readout as described previously (Chen et al., 2015). Briefly, in a 15 ml conical 
tube, we added 6 ml of NK Lysis Buffer (50 mM Tris (Boston BioProducts), 50 mM EDTA (Ambion), 1% 
SDS (Invitrogen), pH 8), and 30 μl of 20 mg/ml Proteinase K (Qiagen) to 9 million cells (>500 coverage) 
and incubated at 55°C overnight. 30 μl of 10 mg/ml RNAse A (Qiagen, diluted in NK Lysis Buffer to 10 
mg/ml and then stored at 4 °C) was added to the lysed sample, which was then inverted 25 times and 
incubated at 37°C for 30 minutes. Samples were cooled on ice before the addition of 2 ml of pre-chilled 
7.5M ammonium acetate (Sigma) to precipitate proteins. After adding ammonium acetate, the samples 
were vortexed at high speed for 20 seconds and then centrifuged at ≥ 4,000 x g for 10 minutes. After 
the spin, a tight pellet was visible in each tube and the supernatant was carefully decanted into a new 
15 ml conical tube. 6 ml 100% isopropanol was added to the tube, inverted 50 times, and centrifuged 
at ≥4,000 x g for 10 minutes. Genomic DNA was visible as a small white pellet in each tube. The 
supernatant was discarded, 6 ml of freshly prepared ice-cold 70% ethanol was added, the tube was 
inverted 10 times, and then centrifuged at ≥4,000 x g for 1 minute. The supernatant was discarded by 
pouring; the tube was briefly spun, and the remaining ethanol was removed using a P200 pipette. After 
air-drying for 10-30 minutes, the DNA changed appearance from a milky white pellet to slightly 
translucent. At this stage, 500 μl of 1x TE buffer (Sigma) was added, the tube was incubated at 65°C 
for 1 hour and then overnight at room temperature to fully resuspend the DNA. The next day, the gDNA 
samples were vortexed briefly. The gDNA concentration was measured using a Nanodrop (Thermo 
Scientific). 
5 PCR1 reactions were used for 52 µg of DNA for >500x coverage. Per PCR tube, 10.4 µg of genomic 
DNA was used in 100 µL volume with 0.4 µL Taq-B Polymerase (Enzymatics), 10X Taq buffer 
(Enzymatics), 10 mM dNTPs (NEB), 10 µM Fwd (5’ GAGGGCCTATTTCCCATGATTC), and Rvs (5’ 
GTTGCGAAAAAGAACGTTCACGG) using the following PCR protocol: Denaturation 94 °C for 30s, 25 
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cycles of 94 °C for 10s, 55 °C for 30s, 68 °C for 45s, final elongation 68 °C for 2 min. For the addition 
of Illumina barcodes, 5 staggered forward primers and 1 reverse primer with specific barcodes 
containing Illumina adaptors were mixed to obtain 10 µM primer mix. 2 PCR2 reactions were used 
per timepoint with 5 µL of PCR1 product amplified with 25 µL Q5 High Fidelity 2X Master Mix (NEB), 
5 µL of 10 µM primer mix in 50 µL volume using the following PCR protocol: Denaturation 98 °C for 
30s, 10 cycles of 98 °C for 10s, 65 °C for 30s, 72 °C for 45s, final elongation 72 °C for 5 min. All 
samples were pooled in equimolar ratio and PCR purified pooled sample with QIAquick PCR 
Purification Kit (Qiagen). The purified sample was then run on a 2% E-Gel and the correct size band 
was extracted for PCR2 (250-270 bp) and purified with QIAquick Gel Extraction Kit (Qiagen). The 
pooled library was then quantified with a Low-Range Quantitative ladder on 2% E-Gel. Libraries were 
then sequenced on Illumina MiSeq v3 for 150 cycles single end at the genomics core facility at NYU.  
Sequences flanking the 20 nucleotide sgRNA sequence were trimmed using cutadapt. The 
remaining 20 nucleotide sgRNA sequence reads were aligned to a library index generated by 17820 
sgRNA sequences using bowtie. Each sgRNA ratio was calculated by normalizing to the total reads 
captured per timepoint to be used for downstream analysis.   
Human TF CRISPR screen 
NYGCe001-A human embryonic stem cells (derived from HUES66) were used for the human TF 
CRISPR screen (Lu and Sanjana, 2019). NYGCe001-A cells were maintained using the Enhanced 
Culture Platform (ECP), as described previously by Cowan and colleagues (Schinzel et al., 2011). 
Briefly, hESCs were cultured in Essential 8 media (Thermo Fisher) supplemented with 100 μg/mL 
Normocin (InvivoGen) and cultured in standard tissue culture dishes coated with Geltrex (Thermo 
Fisher) at 37 °C in 5% CO2. Accutase (STEMCELL) was used for passaging the cells. 10 μM Rho 
kinase inhibitor (ROCKi) Y-27632 (MilliporeSigma) was added to the culture medium at each passage. 
ROCKi was removed at the subsequent media change (typically 24 hours later). 
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For the Human TF CRISPR-Cas9 library, we designed sgRNAs to target 1891 known human TFs using 
the GUIDES web tool (http://guides.sanjanalab.org) with 10 sgRNAs per TF and also included 1000 
non-targeting (negative control) sgRNAs (Ravasi et al., 2010; Meier, Zhang and Sanjana, 2017). The 
library was cloned and packaged using the same methods described above (Library cloning and 
Lentiviral packaging), except that no BSA was added to concentrated lentivirus. 
Briefly, 80 x 106 NYGCe001-A cells were transduced with human TF CRISPR-Cas9 library lentivirus. 2 
days after transduction, 4 µg/µL Zeocin (Invivogen) were added to culture media, and then cells were 
maintained in selection media for 2 days. After selection, cells were cultured for 24 days, then harvested 
for DNA extraction and library amplification (see DNA extraction and library amplification above). Cells 
were passaged whenever they reached approximately 75% confluence. After each passage, at least 
10 x 106 cells were maintained in culture to ensure ~500-fold coverage of the total number of sgRNAs 
in the Human TF CRISPR library. 
To identify depleted guide RNAs, we compared sgRNA representation from Day 24 post-selection to 
the plasmid library. To identify significantly depleted guides, we assessed how many sgRNAs for each 
TF were depleted below the 5th percentile of non-targeting guide RNAs and also performed robust rank 
aggregation (RRA) analysis. 
Competition experiment with qPCR 
U6-sgRNA-E+F scaffold and EFS-NS-Cas9-P2A-ZeocinR-WPRE digested from pTF vector with AflII 
and HindIII and cloned into the piggyBac backbone (De Santis et al., 2018). sgRNAs targeting Klf5 (5’ 
TGGCGAATTAACTGGCAGAG), Nanog (5’ TGTCCTTGAGTGCACACAGC), Oct4 (5’ 
CCGCCCGCATACGAGTTCTG), Zbtb10 (5’ AGAAACGGCTGCCTGCAACC), Zbtb11 (5’ 
AGCGCACAAGTCTGTCCTCT), Zfp131 (5’ GTTCTTTAAAGTGTCCAAAG) and non-targeting sgRNA 
(5’ GCCGCAACGTTAGATGTATA) were cloned into piggyBac plasmids. Equimolar ratio (0.5 µg) of 
plasmids were pooled and co-nucleofected (Lonza) with 0.5 µg pBac transposase to mESCs (De Santis 
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et al., 2018). DNA was collected with >10000 cells per sgRNA coverage d1, d3, d6, d9, and d13 post-
transduction. PCR1 reaction described above was used to amplify the sgRNA construct from the 
genome. qPCR primers were designed to overlap sgRNA and scaffold (5’ 
CGGTGCCACTTTTTCAAGTTG). 10 µL Maxima SYBR Green brilliant PCR amplification kit (Thermo 
Scientific), 5 uL forward and reverse primer mix (2 nM), 5 µL of PCR1 reaction (2 ng) were combined 
for the qPCR reaction using CFX 96 Touch Biorad qPCR thermocycler (Biorad). Δct was calculated by 
subtracting the mean Cq of each sgRNA to a non-targeting control. ΔΔct was calculated by subtracting 
the Δct of each timepoint from the d1 original abundance. The average depletion rate was drawn with 
error bars (n=3). 
Oct4::TdTomato Sox2::Gfp experiments 
5x105 Oct4::tdTomato Sox2::Gfp cells were plated at a single-cell density to 6-well plates and after 
attachment to the plate, transduced with 36 sgRNAs (3 positive controls (Klf5, Nanog, Oct4), 2 non-
targeting negative controls and 7 candidate TFs). Transduced cells were selected on 50 ng/µL zeocin 
for 5 days post-transduction. ESCs were cultured in +2i+LIF media conditions for the initial 4 days and 
media conditions switched to -2i-LIF for 24h before proceeded to FACS.      
Immunocytochemistry 
Embryonic stem cells were fixed with 4% paraformaldehyde in 1X PBS for 10 mins, washed 3 times 
with 1X PBS, treated with 0.02% Triton-X (Thermo Fisher) for 10 mins and then with blocking buffer for 
30 mins (10% FBS, 0.05% NaAz in 1X PBS), stained with primary antibody overnight at 4°C, washed 
3 times with 1X PBS, stained with secondary antibody at room temperature for 1h, washed 3 times with 
1X PBS and mounted with Fluoroshield with DAPI (Sigma). Images were acquired with a Nikon Perfect 
Focus Eclipse Ti live-cell fluorescence microscope. We used antibodies to V5 (R960-25, Thermo Fisher 
Scientific; 1:5000), OCT3/4 (Sc-5279, Santa Cruz; 2mg/ml), GFP (ab13970, Abcam; 1:5000), HA 
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(ab9110, Abcam; 1:5000), Alexa 488 (A-11029, A-11015), Alexa 568 (A-11036) secondary antibodies 
were used (Thermo Fisher, 1:2000). 
Competition experiments with H2B-GFP 
106 H2B-GFP cells were co-plated with 106 E14Tg2a wt, iZbtb10-HA Zbtb10Δ, iZbtb11-HA Zbtb11Δ 
and iZfp131-HA Zfp131Δ cells on 6-well plates and grown in +2i+LIF conditions without doxycycline. 
Cells were fixed d1 and d5 after plated and stained for GFP to calculate GFP/DAPI ratio. Due to plating 
error, d1 values were normalized to 1:1 and d5 values were calculated according to the normalization. 
Competition rates were calculated with error bars (n=3).    
RNA-Seq  
Cells were collected after grown for 3d in +2i or -2i conditions in the absence of doxycycline. TRIzol LS 
Reagent (LifeTechnologies) was used to extract RNA and RNAeasy mini kit (Qiagen) and used to purify 
RNA. Agilent High Sensitivity RNA Screentape (Agilent) was used to determine RNA integrity. 500 ng 
RNA from cells that was spiked-in with ERCC Exfold Spike-in mixes (Thermo Fisher, 4456739) was 
used for the generation of RNA-seq libraries. TruSeq Stranded mRNA Library Preparation kit (Illumina, 
20020594) was used to prepare RNA-seq libraries. High Sensitivity DNA ScreenTape (Agilent, 5067-
5584) was used to verify library sizes. A KAPA library amplification kit was used on Roche Lightcycler 
480 to quantify the library prior to sequencing. Libraries were sequenced on Illumina NextSeq 500 using 
V2.5 chemistry (75 cycles, single-end 75bp) at the Genomics Core Facility at NYU. 
ChIPseq 
Wildtype and mutant cells were collected after being grown for 3d in +2i or -2i conditions in the presence 
or absence of 3 ng/uL doxycycline. 1 mM DSG (ProteoChem) was used for crosslinking at RT for 15min. 
1% Formaldehyde (vol/vol) was added for an additional 15min until quenched with glycine (Sigma). 
Cells were separated into aliquots of 25x106 and centrifuged to freeze pellets at -80°C. Thawed cells 
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were lysed in 5mL of 50 mM HEPES-KOH pH 7.5 (Gibco), 140 mM NaCl (Thermo Fisher), 1 mM EDTA 
pH 8.0, 10% glycerol (vol/vol) (Thermo Fisher), 0.5% Igepal (vol/vol) (Sigma), 0.25% Triton X-100 
(vol/vol) with 1×protease inhibitors (Roche) for 10min at 4°C. Cells were centrifuged for 5min at 1100 
rpm and resuspended in 5mL of 10 mM Tris-HCl pH 8.0 (Boston BioProducts), 200 mM NaCl, 1 mM 
EDTA pH 8.0, 0.5 mM EGTA pH 8.0 (Boston BioProducts) with 1×protease inhibitors, and incubated 
for an additional 10 min at 4°C on a rotating platform. Cells were centrifuged for 5min at 1100 rpm and 
resuspended in 2mL of Sonication Buffer (50 mM Hepes pH 7.5, 140 mM NaCl, 1 mM EDTA pH 8.0, 1 
mM EGTA pH 8.0, 1% Triton X-100 (vol/vol), 0.1% sodium deoxycholate (wt/vol), 0.1% SDS (vol/vol) 
with 1×protease inhibitors). Sonication was performed in two Bioruptor tubes per sample with 0.45 g 
sonication beads. Bioruptor Pico (Diagenode) was used for 18 cycles of 30 sec on and 30 sec off to 
sonicate to an average size of approximately 200 bp. To immunoprecipitate, Dynabeads protein-G 
(Thermo Fisher) and antibodies (HA, H3K4me3, H3K27me3, H3K27ac, SIN3A, CHD4) were incubated 
with sonicated chromatin for 16h at 4°C on a rotating platform. After the immunoprecipitation, the 
sample was washed with sonication buffer, high salt sonication buffer (500 mM NaCl, LiCl wash buffer 
(20 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 250 mM LiCl (Sigma), 0.5% Igepal (vol/vol), 0.5% sodium 
deoxycholate (wt/vol)), and TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8). The sample was 
eluted in elution buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0, 1% SDS (vol/vol)) by incubating 
for 45min at 65°C. Crosslinks were reversed by incubating the sample for 16h at 65°C. RNA was 
removed by 0.2 mg/mL RNAse A (Sigma) in 200 μL of TE for 2h at 37°C. To remove protein, 0.2 mg/mL 
Proteinase K (Invitrogen) and CaCl2 (Sigma) were added and the sample incubated at 55°C for 30min. 
DNA was first purified with phenol:chloroform:isoamyl alcohol (25:24:1; vol/vol) (Invitrogen) and then 
by performing salt-ethanol precipitation. DNA pellets were resuspended in 50 uL H2O. Illumina DNA 
sequencing libraries were prepared with half of the ChIP sample and a 1:100 dilution of the input sample 
in H2O. Library preparation was performed with end repair, A-tailing, and ligating multiplexed adapters 
(Illumina-compatible Bioo Scientific). Agencourt AmpureXP beads (Beckman Coulter) were used to 
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remove unligated adapters. Libraries were then amplified by PCR with TruSeq primers (Sigma) and 
Phusion polymerase (New England Biolabs). Libraries with sizes ranging between 250-550bp were gel 
purified (Qiagen). KAPA library amplification kit was used on Roche Lightcycler 480 to quantify the 
library prior to sequencing. Libraries were sequenced on Illumina NextSeq 500 using V2.5 chemistry 
(75 cycles, single-end 75bp) at the Genomics Core Facility at NYU. 
scRNAseq 
Zbtb11Δ and Zfp131Δ cells were mixed with H2B-GFP expressing wt cells in a 9:1 ratio to have 1000 
cells/ul. CellTrics 30 μM (Cat #04–004-2326) was used to remove debris and clumps. 10X Genomics 
Chromium Single Cell 3’ library kit was used to generate the single-cell library with a cell recovery rate 
of 10.000 cells (120262 Chromium™ i7 Multiplex Kit, 120236 Chromium™ Single Cell 3’ Chip Kit v2, 
120237 Chromium™ Single Cell 3’ Library & Gel Bead Kit v2). Agilent High Sensitivity DNA D1000 
Screentape (5067– 5585) was used to detect fragment length distribution of the library.  KAPA library 
amplification kit was used on Roche Lightcycler 480 to quantify the library prior to sequencing. Libraries 
were sequenced on Illumina NovaSeq 6000 using SP chemistry (100 cycles, 26x98 bp) at the 
Genomics Core Facility at NYU.  
Candidate TF identification with False Discovery Rate 
In the False Discovery Rate method, for each time point, normalized counts of each sgRNA were 
calculated. Log2 scores were then calculated and ranked by taking the log2 of the final count divided 
by the initial count. We set the thresholds for calling depleted and enriched targeting sgRNAs setting 
an empirical <0.05 false discovery rate (FDR). Any targeting sgRNA that was underrepresented less 
than 50th most underrepresented non-targeting sgRNA was determined to be a depleted sgRNA with 
FDR <0.05 (marked by orange in Figure 1C, S2C). Conversely, any sgRNA that was overrepresented 
more than the 50th most overrepresented non-targeting sgRNA was determined to be an enriched 
sgRNA with FDR<0.05 (marked by blue in Figure 1C, S2C). Depleting and enriching sgRNAs were then 
appointed to genes to determine how many sgRNAs were depleted or enriched per each gene.  
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Candidate TF identification with Linear Model 
After normalization, a mixed linear model (Gelman and Hill 2006) was used to evaluate guide 
enrichment or depletion. The model has the following formula: 
𝑦𝑖𝑗 = 𝛽0 + 𝑥𝑗𝛽1 + 𝑏0𝑖 + 𝜖𝑖𝑗      (1) 
 
Where 𝑦𝑖𝑗 is the log counts of guide 𝑖 at the 𝑗-th time point; 𝛽0 is the overall intercept; 𝛽1 is the overall 
slope for time; 𝑥𝑗 is the 𝑗-th time point ; 𝑏0𝑖 is the random intercept for guide 𝑖 and 𝜖𝑗 is the random error. 
A random intercept model was chosen to account for the variability in the guides' initial observed counts. 
Hypothesis testing was done using the likelihood ratio test via ANOVA (Kaufmann and Schering, 2014). 
The model was compared to a reduced version that does not account for time. P-value adjustment was 
performed using the Holm (Sture Holm 1979) method. An adjusted p-value < 0.05 was used to identify 
candidates. 
To take advantage of the time course data captured throughout our experiment, the linear model was 
modified to classify each of the hits as early, late, or a stably depleting gene. In this new model, the 








𝑙𝑎𝑡𝑒𝛽𝑙𝑎𝑡𝑒 + 𝑏0𝑖 + 𝜖𝑖𝑗        (2) 
Hypothesis testing was performed as described above. Depending on the significance of each time 
factor, our genes were classified as follows:  
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“Early depleting” genes include core cellular machinery and the core PGRN TFs Oct4 and Nanog 
(Figure S4B-D). “Stable and late depleting” genes include cellular stress and DNA repair factors along 
with accessory TFs in the PGRN, such as Tfcp2l1 (“stable depleting”), Stat3 (“late depleting”), and 
Nr0b1 (“late depleting”) (Figure S4B, E-G). Accessory TFs do not rapidly deplete due to the time 
required for their mutations to exert an effect on the levels of core TFs. The screen depth and time 
series were sensitive enough to identify sgRNAs targeting partially redundant genes like Klf2 and Klf5 
as “late depleting” TFs (Figure S4H, I). 
RNAseq Data Processing 
RNA-seq fastq files were aligned to the mouse genome (version mm10) using Hisat2 (version 2.1.0) 
(Kim, Langmead and Salzberg, 2015). FeatureCounts R package was used to assign reads to genomic 
features (Liao, Smyth and Shi, 2014). The DESeq2 package was used for differential gene expression 
analysis and data visualization (volcano plots, heatmaps, PCA plots)(Love, Huber and Anders, 2014). 
A q-value cutoff of < 0.01 was used for significantly misregulated genes. PANTHER (version 14) 
(http://geneontology.org) was used to perform Gene Ontology term enrichment analysis (Mi et al., 
2019). 
scRNAseq Data Processing 
Fastq files were generated by using 10X Genomics CellRanger (version 4.0.0) with default settings. 
New fasta and annotation files were created using mkref in mm10 for the detection of the H2B::GFP 
sequence (Addgene #11680). CellRanger count function was used to assign reads to genomic features. 
7510 cells were estimated for Zbtb11Δ and H2B-GFP population whereas 6982 cells were estimated 
for Zfp131Δ and H2B-GFP population. Seurat R package (version 3.0) was used for differential gene 
expression analysis and data visualization (UMI plots, violin plots, gene-specific UMI plots)(Stuart et 
al., 2019).  
ChIP-seq Data Processing and Differential Analysis 
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Fastq files were aligned to the mouse genome (mm10) using Bowtie (v1.0.1) with options “-q–best–
strata -m 1–chunkmbs 1024”. MultiGPS (v.0.74) was used to call peaks after alignment on all 
transcription factors. A q-value cutoff of <0.01 was used to identify significant binding events. Histone 
modification and ATAC-seq peaks were called using the DomainFinder module in SeqCode 
(https://github.com/seqcode/seqcode-
core/blob/master/src/org/seqcode/projects/seed/DomainFinder.java). Contiguous 50-bp genomic bins 
with significantly higher read enrichment compared with normalized input were identified (binomial test, 
p <0.05). Differential binding and modification analyses were done using DESeq2 (v1.28.1) with an 
adjusted p-value cutoff of <0.05 and all default options. To create the count matrix for DESeq2, peaks 
were first called independently in the wildtype and knockout ChIP-seq datasets. Overlapping peak 
regions were merged between the wt and KO. Peak regions found exclusively in either file were also 
included. The final count matrix was created using Bedtools coverage with the “-counts” option 
separating each replicate into its count column. Before running DESeq2 on the matrix, counts were 
normalized by the length of the corresponding region for histone modifications (domains have differing 
lengths).  
Motif Finding 
For motif finding, the top 1000 peaks were selected from each zinc finger ChIP-seq dataset based on 
MultiGPS q-value. Following this, bedtools getFasta was used to retrieve the sequences underlying 
these binding events. Sequences were fed through RepeatMasker (v4.0.7) on default parameters. 
Finally, meme-chip from the MEME suite (v4.11.3) was performed on the masked sequences using the 
options “-meme-nmotifs 5 -meme-mod zoops -meme-minw 6 -meme-maxw 20”. 
Data Visualization for Heatmaps and Profile Plots 
Heatmaps and profile plots were generated using Deeptools (v3.1.3). Bigwigs were created directly 
from the BAM files using RPKM normalization within Deeptools bamCoverage (--binSize 50 --
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normalizeUsing RPKM). Other normalizations were also tested. Using RPKM normalization kept the 
noise the same visually between replicates and conditions when plotting 5000 random regions in the 
genome (for within-study datasets). Replicates were concatenated together before creating the bigwig 
file as suggested by the Deeptools manual. Matrices for the heatmaps and profile plots were created 
using Deeptools computeMatrix with the options “reference-point --referencePoint center -a 1000 -b 
1000”. Heatmaps themselves were generated using Deeptools plotHeatmap with all default options 
outside of changing sample colors. Max values were chosen by comparing 5000 random noise regions 
in each sample for within-study data and inspecting these visually. The datasets retrieved from other 
studies had significantly more noise than from our own. Profile plots were created using Deeptools 
plotProfile with the option “--perGroup”.  
Overlap Analysis for ChIPseq Data 
Overlap percentages were calculated using bedtools intersect with the “-u” option. The first file or “-a” 
was always the zinc finger. In other words, the percentages represent the number of zinc finger peaks 
(A) that intersect the other transcription factor or histone modification regions (B) in question. For figure 
5A, ZBTB11 was used as “-a.” Observed/expected values in Figure 5B were calculated using a python 
script. In brief, this script created bed files that had the same number of regions and lengths of the 
regions within the second bed file (B) and intersected these with the zinc finger bed files (A). The script 
discounted blacklist regions to increase accuracy. This was performed 30 times to get the average 
number of times one would expect file A to overlap with file B. The mean was used as expected in 
Figure 5 and the actual value from our data was used as the observed.  
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Figure 1. Identification of transcription factors required for pluripotency using the 
CRISPR TF library.  
(A) Transcription factor screen overview. Day -1: CRISPR TF library transduction to 
growing ESCs. Day 0: Zeocin selection begins. Day 5, 8, and 12: collection days and 
representation analysis.  
(B) Shannon’s diversity index (H) calculated based on the proportion of individual sgRNAs 
(pi) in the total number of sgRNAs in the pool (S) for each time point with sgRNA counts. 
The diversity score decreases as essential, and pluripotency targeting sgRNAs are lost 
from the population.  
(C) Log2 fold change of targeting sgRNAs on day 12 compared to the initial library 
representation. sgRNAs depleted more than the 50th most depleted non-targeting sgRNA 
are in orange and enriched more than the 50th most enriched non-targeting sgRNA are in 
blue. 
(D) The number of TF library sgRNAs depleted and mean sgRNAs number with random 
depletion calculated by 1000 permutation tests for the different number of sgRNA per 
gene. TFs with more than or equal to 6 depleted sgRNAs are unlikely to be false positives.  
(E) Venn diagram representation of the number of depleted TFs identified by three 
different methods: Log-fold change, linear modeling, and MAGeCK. 196 genes were 
picked as high confidence depleted TFs by all methods.  
(F) The workflow of secondary screen based on the Oct4::tdTomato Sox2::Gfp 
pluripotency reporter ESC line. Pluripotent ESCs are depicted as yellow while 
differentiating cells lose one or both reporter expression.  
(G) Percentage of cells expressing fluorescent reporters when transfected with a single 
sgRNA that is either non-targeting, targeting a known pluripotency TF, or candidate TF. 
80% of cells infected with non-targeting sgRNA express both reporters. This number 
decreases in cells infected with sgRNAs targeting known pluripotency TFs and Zbtb10, 
Zbtb11, and Zfp131.  
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Figure 2. Zbtb11Δ and Zfp131Δ mutant cells express multiple lineage-specific 
markers. 
(A) Zbtb10Δ, Zbtb11Δ and Zfp131Δ colony morphology in +2i+LIF and -2i+LIF conditions 
3d after doxycycline removal. Zbtb11Δ and Zfp131Δ cells lose typical ESC colony 
formation ability and adopt morphologies associated with differentiation. Scale bar = 200 
µm. 
(B) Volcano plots of log2 fold change of transcripts expressed in Zbtb10Δ, Zbtb11Δ, and 
Zfp131Δ cells versus wildtype (wt) cells grown in the absence of doxycycline for 3d in -
2i+LIF media (n=2). Significant changes (* p<0.05) marked in color for each genotype. 
Zbtb11 and Zfp131 mutations in ESCs induce aberrant gene expression.  
(C) Hierarchical clustering of transcriptomes of wildtype, Zbtb10Δ, Zbtb11Δ, and Zfp131Δ 
cells grown in the absence of doxycycline for 3d in -2i+LIF and +2i+LIF media. R1 and 
R2 denote two different replicates. Zbtb11Δ and Zfp131Δ cells have enough 
transcriptomic differences to cluster away from control and Zbtb10Δ cells in both culture 
conditions.  
(D) Principle component analysis of transcriptomes of wildtype, Zbtb10Δ, Zbtb11Δ, and 
Zfp131Δ cells grown in the absence of doxycycline for 3d in -2i+LIF and +2i+LIF media 
(n=2). Individual circles and triangles represent a single replicate. Zbtb11 and Zfp131 
mutations induce profound transcriptomic changes separating mutant cells from wt and 
Zbtb10 mutant cells along PC1. 
(E) GO-enrichment analysis of significantly upregulated genes in Zbtb11Δ (531) and (F) 
Zfp131Δ (839). Zbtb11 and Zfp131 mutations induce ESCs to express genes with a 
strong developmental signature.  
 
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 

























































































































0 1 2 3 4 5 6
Clusters
2.5
7 0 1 2 3 4 5 6
Clusters
7 0 1 2 3 4 5 6
Clusters
7 0 1 2 3 4 5 6
Clusters

























































































































































Pluripotency Mesoderm Endoderm Ectoderm Trophectoderm
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted November 23, 2020. ; https://doi.org/10.1101/2020.11.23.391771doi: bioRxiv preprint 
Figure 3. Zbtb11Δ and Zfp131Δ mutant cells differentiate into multiple lineages. 
(A) The log2 fold change of developmentally regulated TFs obtained from bulk RNAseq 
experiment in Zbtb11Δ and Zfp131Δ cells versus wt in +2i+LIF and -2+LIF conditions. 
(n.s. Not significant, * < 0.05, ** < 10-5, *** < 10-10) (n=2). Zbtb11 and Zfp131 mutations 
induce the expression of TFs associated with all three embryonic layers while 
downregulating pluripotency TFs.  
(B) Uniform manifold approximation and projection (UMAP) plot of Zbtb11Δ and H2b::Gfp 
(internal control) cells single-cell RNA-seq (n=1).  
(C) Violin plots of genes expressed in each cluster in Zbtb11Δ and H2b::Gfp cells. ESC, 
mesoderm, endoderm, ectoderm markers are expressed in distinct clusters. 
(D) Expression of genes associated with pluripotency and germ layers in Zbtb11Δ cells. 
Zbtb11Δ cells segregate in different clusters compared to H2b::Gfp and express 
developmentally regulated genes.  
(E) UMAP plot of Zfp131Δ and H2b::Gfp (internal control) cells single-cell RNA-seq (n=1).  
(F) Violin plots of genes expressed in each cluster in Zfp131Δ and H2b::Gfp cells. ESC, 
mesoderm, endoderm, ectoderm markers are expressed in distinct clusters. 
(G) Expression of genes associated with pluripotency and germ layers in Zfp131Δ and 
H2b::Gfp UMAP plots. Zfp131Δ cells segregate in different clusters compared to H2b::Gfp 
and express developmentally regulated genes. 
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Figure 4. ZBTB11 and ZFP131 bound sites gain an H3K4me3 signal in Zbtb11Δ and 
Zfp131Δ mutant cells.  
(A) ChIP-seq heatmap for ZBTB11 and ZFP131 binding on the ESC genome (n=2). 
Categories were identified with ZBTB11 and ZFP131 cobinding (Z11=Z131), differentially 
enriched ZBTB11 binding (Z11>Z131) and differentially enriched ZFP131 binding 
(Z131>Z11). 
(B) Enriched motifs discovered via MEME-ChIP for each category of ZBTB11 and 
ZFP131 binding. Motif discovery was performed with centering to the peak at ZBTB11 
and ZFP131 for three differential binding categories. 
(C) Percentage of overlap between ZBTB11 and ZFP131 with pluripotency factors, known 
regulatory complex members, histone modifications, and ATAC-seq signal. ZBTB11 and 
ZFP131 bind at sites with active chromatin states, accessible and enriched with TrxG, Pol 
II S5P, NELF and histone deacetylase members. ZBTB11 and ZFP131 do not co-bind 
with pluripotency TFs but bind to regions with active chromatin signatures.  
(D) Metagene plots for H3K4me3 difference at ZBTB11 bound sites in Zbtb11Δ versus wt 
(n=2), (E) at ZFP131 bound sites in Zfp131Δ versus wt (n=2), and (F) at ZBTB11 and 
ZBTB131 cobound sites in Zbtb11Δ and Zfp131Δ versus wt. Zbtb11 and Zfp131 
mutations result in an H3K4me3 gain at ZBTB11 and ZFP131 binding sites.  
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Figure 5. SETD1A occupancy at ZBTB11 and ZFP131 sites.  
(A) ChIP-seq heatmap for ZBTB11 and (B) ZFP131 overlap with SETD1A and H3K4me3. 
Categories are determined according to gain, loss or no change in H3K4me3 signal 
between mutant and wt cells (n=2 for all). ZBTB11 and ZFP131 coocupy ESC genome 
with SETD1A. 
(C) Metagene plots for H3K4me3 signal difference in ZBTB11 and SETD1A co-bound 
sites in Zbtb11Δ versus wt, (D) in ZFP131 and SETD1A co-bound sites in Zfp131Δ versus 
wt, (E) in ZBTB11, ZFP131 and SETD1A co-bound sites in all three lines (n=2 for all). 
ZBTB11 and ZFP131 removal induced H3K4me3 gain at SETD1A present sites in wt 
cells.  
(F) GO-enrichment analysis of significantly upregulated genes with ZBTB11 binding and 
H3K4me3 increase (n=531) and (G) with ZFP131 binding and H3K4me3 increase 
(n=264). Gene Ratio is calculated with the number of occurrences in specific GO 
categories divided by the total amount of genes. GO-terms are associated with 
differentiation. 
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Figure 6. POL II S5P and NELF promoter-proximal pausing complex overlaps 
ZBTB11 and ZFP131 sites.  
(A) ChIP-seq heatmap for ZBTB11 and ZFP131 overlap with POL2 S5P and NELF. 
Categories are determined according to ZBTB11 only, ZFP131 only and cobound regions 
(n=2 for all). ZBTB11 and ZFP131 bind at sites with POL II S5P and NELF in ESCs. 
(B) Metagene plots for NELF signal difference in ZBTB11 only, ZFP131 only and cobound 
regions (n=2 for all).  ZBTB11 and ZFP131 sites lose NELF in Zbtb11 and Zfp131 mutant 
ESCs. 
(C) Violin plots for z-score mRNA expression of genes that are ZBTB11 bound along with 
NELF and POL II S5P with H3K4me3 increase in Zbtb11 mutant (n=1191), (D) ZFP131 
bound along with NELF and POL II S5P with H3K4me3 increase in Zfp131 mutant 
(n=915), (E) ZBTB11 and ZFP131 bound along with NELF and POL II S5P with H3K4me3 
increase in Zbtb11 mutant (n=216), and (F) ZBTB11 and ZFP131 bound along with NELF 
and POL II S5P with H3K4me3 increase in Zfp131 mutant (n=216). ZBTB11 and ZFP131 
genes with paused POL II become transcribed in Zbtb11 and Zfp131 mutant ESCs.  
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Figure 7. ZBTB11 and ZFP131 maintain developmentally regulated genes at a 
poised state. Schematic overview of the mode-of-action of ZBTB11 and ZFP131 in 
ESCs. ZBTB11 and ZFP131 bind proximal to developmentally regulated genes. These 
genes contain promoter-proximal paused POL II and NELF, and chromatin features 
associated with poised states. Upon ZBTB11 and ZFP131 removal, TrxG increases 
activity, and POL II transcribes pro-differentiation genes causing ESC to differentiate and 
exit their pluripotent state.  
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